磁共振引导放疗推动局限性前列腺癌治疗进展
本文讨论磁共振引导放疗(MRgRT)在局限性前列腺癌外照射放疗中的应用前景。MRgRT将直线加速器与MRI扫描仪结合,可在每次放疗前显示盆腔解剖并重新规划剂量分布,通过缩小边界和改进靶区剂量投递来扩大治疗窗;前列腺癌生物学特征适合超低分割,可将放疗减至仅5次,近期研究显示对前列腺内肿瘤行局灶剂量提升至高消融剂量可大幅提高无病生存率。
要点
- MRgRT可在每次分割前显示盆腔解剖并重新规划剂量分布。
- MRgRT通过缩小边界和改进靶区剂量投递扩大外照射放疗治疗窗。
- 前列腺癌适合超低分割,放疗可减至仅5次;局灶剂量提升可提高无病生存率。
核心结论
- MRgRT具有扩大外照射放疗治疗窗的潜力,对前列腺癌尤其有前景,本文讨论这些独特机会及未来潜在获益。
研究设计与样本
- 本文为讨论MRgRT在局限性前列腺癌治疗中应用机会与未来获益的综述性文章。
主要发现
- MRgRT采用直线加速器与MRI扫描仪结合的混合系统,可在每次放疗分割前显示盆腔解剖并重新规划剂量分布。
- MRgRT通过缩小边界和改进靶区剂量投递来更好地保护正常组织,从而可能扩大外照射放疗的治疗窗。
- 前列腺癌生物学特征适合超低分割,可将放疗治疗减少至仅5次。
- 近期研究显示,对前列腺内肿瘤行局灶剂量提升至高消融剂量可大幅提高无病生存率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
External beam radiotherapy (EBRT) is an important cornerstone in the treatment of localized prostate cancer. Current image-guided radiotherapy (IGRT) techniques allow for more accurate and precise delivery of radiation treatment by the use of imaging before each fraction. Magnetic resonance guided radiotherapy (MRgRT) is the next step in IGRT with hybrid systems combining linear accelerators with MRI-scanners. With MRgRT, it is possible to visualize pelvic anatomy in great detail and subsequently perform replanning of the radiation dose distribution before each radiotherapy fraction. This technique has the potential to increase the therapeutic window of EBRT, by improved normal tissue sparing due to margin reduction and more accurate target dose delivery. This is particularly promising for prostate cancer, with its biology lending itself to ultra-hypofractionation, reducing radiotherapy treatment to as little as five fractions. Also, recent studies have shown that focal dose escalation to the intraprostatic tumor to high ablative doses can substantially increase disease-free survival. In this article, we discuss these unique opportunities as well as the potential future benefits of MRgRT in prostate cancer treatment.
引用
- Reijnen C, Brunenberg EJL, Kerkmeijer LGW, et al. Advancing the treatment of localized prostate cancer with MR-guided radiotherapy. Prostate Cancer Prostatic Dis. 2022. PMID: 36550217. doi:10.1038/s41391-022-00632-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。